focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Investec Starts Wolseley With Hold Rating

Wed, 12th Oct 2016 08:27

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
TRADERS: INVESTEC INITIATES WOLSELEY WITH 'HOLD'
----------
DEUTSCHE BANK RAISES SHIRE PRICE TARGET TO 6200 (6000) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES GLAXOSMITHKLINE PRICE TARGET TO 1870 (1800) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 6200 (5800) PENCE - 'BUY'
----------
TRADERS: MERRILL LYNCH REMOVES BT GROUP FROM 'EUROPE 1 LIST'
----------
GOLDMAN RAISES VODAFONE PRICE TARGET TO 275 (265) PENCE - 'NEUTRAL'
----------
UBS RAISES BURBERRY PRICE TARGET TO 1800 (1650) PENCE - 'BUY'
----------
FTSE 250
----------
HSBC RAISES PAGEGROUP PRICE TARGET TO 385 (320) PENCE - 'HOLD'
----------
BARCLAYS RAISES PAGEGROUP PRICE TARGET TO 390 (340) PENCE - 'EQUAL WEIGHT'
----------
GOLDMAN RAISES PAGEGROUP PRICE TARGET TO 347 (333) PENCE - 'SELL'
----------
TRADERS: KEPLER CHEUVREUX RAISES PAGEGROUP TO 'HOLD' ('REDUCE')
----------
LIBERUM RAISES ASHMORE GROUP TO 'HOLD' ('SELL') - PRICE TARGET 379 (240) PENCE
----------
DEUTSCHE BANK RAISES ZOOPLA PROPERTY PRICE TARGET TO 300 (280) PENCE - 'HOLD'
----------
Investec Lifts OneSavings Bank Target To 360p From 355p, Keeps At Buy
----------
Cantor Fitzgerald Cuts Sports Direct Target To 260p From 320p, Hold
----------
BERENBERG RAISES VICTREX PRICE TARGET TO 1650 (1510) PENCE - 'HOLD'
----------
CITIGROUP RAISES ELECTROCOMPONENTS TO 'NEUTRAL' ('SELL') - PRICE TARGET 375 PENCE
----------
MAIN MARKET AND AIM
----------
DAVY CUTS PREMIER FOODS TO 'NEUTRAL' ('OUTPERFORM')
----------
PANMURE RAISES ANIMALCARE GROUP PRICE TARGET TO 370 (337) PENCE - 'BUY'
----------
N+1 Lifts Walker Greenbank To Buy From Hold, Target 250p From 200p
----------
LIBERUM CUTS MELROSE INDUSTRIES TO 'HOLD' ('BUY') - PRICE TARGET 200 PENCE
----------
GOLDMAN RAISES SECURE INCOME PRICE TARGET TO 370 (308) PENCE - 'NEUTRAL'
----------

PANMURE CUTS VERNALIS PLC PRICE TARGET TO 65 (76) PENCE - 'BUY'

---------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.